TY  - GEN
AU  - Baruch,Amos
AU  - Mosesova,Sofia
AU  - Davis,John D
AU  - Budha,Nageshwar
AU  - Vilimovskij,Alexandr
AU  - Kahn,Robert
AU  - Peng,Kun
AU  - Cowan,Kyra J
AU  - Harris,Laura Pascasio
AU  - Gelzleichter,Thomas
AU  - Lehrer,Josh
AU  - Davis,John C
AU  - Tingley,Whittemore G
TI  - Effects of RG7652, a Monoclonal Antibody Against PCSK9, on LDL-C, LDL-C Subfractions, and Inflammatory Biomarkers in Patients at High Risk of or With Established Coronary Heart Disease (from the Phase 2 EQUATOR Study)
SN  - 1879-1913
PY  - 2017///0809
KW  - Adolescent
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Biomarkers
KW  - blood
KW  - Cholesterol, LDL
KW  - Coronary Disease
KW  - Cytokines
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Female
KW  - Humans
KW  - Inflammation
KW  - Injections, Subcutaneous
KW  - Magnetic Resonance Spectroscopy
KW  - Male
KW  - Middle Aged
KW  - Proprotein Convertase 9
KW  - immunology
KW  - Risk Factors
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1016/j.amjcard.2017.02.020
ER  -